enzh-TWfrdeitjaptrues
You are here: Home Publications Pub-2018 BTK Cys481Ser drives ibrutinib resistance via ERK1/2, and protects BTK Wild-Type MYD88 mutated cells by a paracrine mechanism

BTK Cys481Ser drives ibrutinib resistance via ERK1/2, and protects BTK Wild-Type MYD88 mutated cells by a paracrine mechanism

Legal | Privacy

Copyright © Bing Center for Waldenstrom's Macroglobulinemia 2000 - 2021